ZNF330

mutation — cross-omics
Cross-omicsMUTATION → DRUGCell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, ZNF330 mutation is significantly associated with the drug of many other genes, with 12 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible ZNF330-associated genes across cancer lineages are AT7867, Dinaciclib, and 50869. Each is linked with ZNF330 in more than 1 cancer types. Because this analysis shows association rather than direction, both ZNF330-to-partner and partner-to-ZNF330 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, AT7867 grouped by ZNF330-low versus ZNF330-high in LARGE_INTESTINE.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (ZNF330→partner) and Y-score (partner→ZNF330) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LARGE_INTESTINEAT7867 →+0.549+2.652.022.04531
LARGE_INTESTINEDinaciclib →+0.548+2.646.033.04721
LARGE_INTESTINE50869 →+0.509+2.649.015.04621
LARGE_INTESTINE776928 →+0.674+2.649.033.04621
LARGE_INTESTINEQuizartinib →+0.356+2.652.027.04521
LARGE_INTESTINEAra-G →+0.220+2.722.008.04021
Each partner links to its Q-omics profile. Showing the 6 strongest of 12 associations by consensus.

AT7867 by ZNF330 expression — LARGE_INTESTINE

Box plot of AT7867 in ZNF330-low vs ZNF330-high samples in LARGE_INTESTINE.

Explore this box plot interactively →

Exploration